Calyxt Identifies More Than 15,000 Unique Chemical Signatures in Lab-Scale BioFactory™ Production Run

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the completion of a key milestone in its lab-scale...

Related Keywords

Minnesota ,United States ,Sarah Reiter ,Calyxt Biofactory ,Travis Frey ,Sherri Spear Cameron Willis ,Michaela Carr ,Exchange Commission ,Calyxt Inc ,Calyxt Business Development Contact ,Nasdaq ,Chief Executive Officer ,Chief Technology Officer ,Looking Statements ,Securities Litigation Reform Act ,Annual Report ,Media Contact ,Investor Relations Contact ,Business Development Contact ,Calyxt ,Nc ,